Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Related Articles by Review for PubMed (Select 18000376)

1.

The dynamics of cancer chromosomes and genomes.

Ye CJ, Liu G, Bremer SW, Heng HH.

Cytogenet Genome Res. 2007;118(2-4):237-46. Review.

PMID:
18000376
2.

Cancer progression by non-clonal chromosome aberrations.

Heng HH, Bremer SW, Stevens J, Ye KJ, Miller F, Liu G, Ye CJ.

J Cell Biochem. 2006 Aug 15;98(6):1424-35. Review.

PMID:
16676347
3.

Clonal and non-clonal chromosome aberrations and genome variation and aberration.

Heng HH, Liu G, Bremer S, Ye KJ, Stevens J, Ye CJ.

Genome. 2006 Mar;49(3):195-204. Review.

PMID:
16604101
4.

Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.

Heng HH, Bremer SW, Stevens JB, Ye KJ, Liu G, Ye CJ.

J Cell Physiol. 2009 Sep;220(3):538-47. doi: 10.1002/jcp.21799. Review.

PMID:
19441078
5.

Cancer genome sequencing: the challenges ahead.

Heng HH.

Bioessays. 2007 Aug;29(8):783-94. Review. Erratum in: Bioessays. 2007 Oct;29(10):1070.

PMID:
17621658
6.

Genomics and proteomics in cancer.

Baak JP, Path FR, Hermsen MA, Meijer G, Schmidt J, Janssen EA.

Eur J Cancer. 2003 Jun;39(9):1199-215. Review.

PMID:
12763207
7.

Karyotype heterogeneity and unclassified chromosomal abnormalities.

Heng HH, Liu G, Stevens JB, Abdallah BY, Horne SD, Ye KJ, Bremer SW, Chowdhury SK, Ye CJ.

Cytogenet Genome Res. 2013;139(3):144-57. doi: 10.1159/000348682. Epub 2013 Apr 3. Review.

8.

The evolutionary mechanism of cancer.

Heng HH, Stevens JB, Bremer SW, Ye KJ, Liu G, Ye CJ.

J Cell Biochem. 2010 Apr 15;109(6):1072-84. doi: 10.1002/jcb.22497. Review.

PMID:
20213744
9.

Array CGH technologies and their applications to cancer genomes.

Davies JJ, Wilson IM, Lam WL.

Chromosome Res. 2005;13(3):237-48. Review. Erratum in: Chromosome Res. 2005;13(4):423.

PMID:
15868418
10.

Genomic mechanisms and measurement of structural and numerical instability in cancer cells.

Bayani J, Selvarajah S, Maire G, Vukovic B, Al-Romaih K, Zielenska M, Squire JA.

Semin Cancer Biol. 2007 Feb;17(1):5-18. Epub 2006 Oct 26. Review.

PMID:
17126026
11.

Clinical implications of advanced molecular cytogenetics in cancer.

Mundle SD, Sokolova I.

Expert Rev Mol Diagn. 2004 Jan;4(1):71-81. Review.

PMID:
14711351
12.

The significance of telomeric aggregates in the interphase nuclei of tumor cells.

Mai S, Garini Y.

J Cell Biochem. 2006 Apr 1;97(5):904-15. Review.

PMID:
16408280
13.

The chromosomal basis of cancer.

Duesberg P, Li R, Fabarius A, Hehlmann R.

Cell Oncol. 2005;27(5-6):293-318. Review.

PMID:
16373963
14.

Future directions in cancer research: impact of the completion of the human genome.

Zoon KC.

Toxicol Pathol. 2004 Mar-Apr;32 Suppl 1:1-2. Review.

15.

[The significance of mutations in genomic evolution].

Chen LL, Peng GZ, Zhang WL, Tian DC.

Yi Chuan. 2006 May;28(5):631-8. Review. Chinese.

PMID:
16735247
16.

Evolutionary plasticity and cancer breakpoints in human chromosome 3.

Ruiz-Herrera A, Robinson TJ.

Bioessays. 2008 Nov;30(11-12):1126-37. doi: 10.1002/bies.20829. Review.

PMID:
18937354
17.

Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1.

Hollox EJ, Barber JC, Brookes AJ, Armour JA.

Genome Res. 2008 Nov;18(11):1686-97. doi: 10.1101/gr.080945.108. Review.

18.

Evolutionary mechanisms and diversity in cancer.

Heng HH, Stevens JB, Bremer SW, Liu G, Abdallah BY, Ye CJ.

Adv Cancer Res. 2011;112:217-53. doi: 10.1016/B978-0-12-387688-1.00008-9. Review.

PMID:
21925306
19.

FISH technology in chromosome and genome research.

Heng HH, Spyropoulos B, Moens PB.

Bioessays. 1997 Jan;19(1):75-84. Review.

PMID:
9008419
20.

Primary chromosome abnormalities in human neoplasia.

Heim S, Mitelman F.

Adv Cancer Res. 1989;52:1-43. Review.

PMID:
2662710
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk